BioSpace News Archive

Policy

Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

March 15, 2020
·
4 min read
Genetown

First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure

Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results

March 15, 2020
·
5 min read
Business

HRA Pharma boosts revenues by 20.8% in 2019

Consumer healthcare company HRA Pharma grew their total group revenues by 20.8% in 2019 with EBITDA growing by 30%

March 15, 2020
·
1 min read
Business

Updated: Arie Belldegrun Diagnosed with COVID-19

Arie Belldegrun, the co-founder and executive chairman of the board of Allogene, disclosed this weekend that he has been diagnosed with COVID-19. The pharma entrepreneur is in self-quarantine and is doing well.

March 15, 2020
·
3 min read
·
Alex Keown
Policy

Advisory - Update on the rifampin drug shortage

Bausch Health, Canada Inc. is releasing a limited number of lots of its tuberculosis drug rifampin, to mitigate a national shortage.

March 15, 2020
·
3 min read
Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research

Innoplexus AG has made its proprietary Ontosight® AI search platform available to medical researchers around the globe to help fight the COVID-19 pandemic with immediate effect.

March 15, 2020
·
2 min read
BioForest

Healthcare Communication Platform, Pulsara, Announces Release of FREE COVID-19 Management Package

Pulsara’s COVID-19 package enables networked communication (including HIPAA-compliant live video and messaging) across organizations at no charge.

March 15, 2020
·
3 min read
Policy

Amarin Takes Proactive Steps to Support Public Health Priorities

Amarin Corporation plc, a leader in preventative cardiovascular risk reduction therapy, announced actions in support of public health initiatives to combat the COVID-19 pandemic.

March 15, 2020
·
13 min read
Genetown

Seres Therapeutics to Virtually Present at the Chardan Microbiome Medicines Summit

Seres Therapeutics, Inc. announced that it will present at the virtual Chardan Microbiome Medicines Summit on Monday, March 16 at 8:15 a.m. ET.

March 15, 2020
·
1 min read
Deals

CureVac focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide

CureVac AG, a clinical stage biopharmaceutical company pioneering mRNA-based drugs for vaccines and therapeutics, confirmed that internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide.

March 15, 2020
·
2 min read